Overview
MOTS-c is a signaling peptide with an unusual origin: it is transcribed from mitochondrial DNA — from within the 12S rRNA gene — rather than the nuclear genome. That places it at the intersection of mitochondrial biology and systemic metabolic signaling, with two characterized mechanisms that operate in different cellular compartments.
Mechanism of Action
In skeletal muscle preparations, MOTS-c activates AMPK indirectly by inhibiting de novo purine biosynthesis, driving intracellular accumulation of AICAR — an endogenous AMPK activator — with downstream effects on glucose transporter translocation, fatty acid oxidation, and mitochondrial biogenesis. Under metabolic stress such as glucose restriction or oxidative challenge, MOTS-c undergoes nuclear translocation — confirmed by immunofluorescence and fractionation across human cell lines — where it engages antioxidant response element machinery alongside NRF2, upregulating cytoprotective gene networks in a stress-responsive pattern.
Specifications
- Purity: ≥99% (HPLC) with mass-spectrometry identity confirmation
- Form: Lyophilized powder
- CAS Number: 1627580-64-6
- Molecular Weight: ~2174.6 g/mol
- Chemical Formula: C₁₀₁H₁₅₂N₂₈O₂₂S₂
- Synonyms: MDP, 12S rRNA-encoded peptide
Research Applications
- AMPK activation and AICAR accumulation studies
- Mitochondrial-encoded peptide biology
- Skeletal muscle glucose metabolism models
- NRF2/ARE nuclear translocation research
- Oxidative stress and cytoprotective gene networks
- Purine biosynthesis pathway inhibition





